Search Results

1 - 10 of 94 items :

  • "venous thromboembolism" x
Clear All
Venous thromboembolism caused by testosterone abuse in a young man with previously undiagnosed genetic thrombophilia

reductase and deep venous thrombosis. Survey of 120 patients in internal medicine. Rev Med Interne. 1998 Jan;19(1):29-33. DOI: 10.1016/S0248-8663(97)83696-X 8. Simone B, Stefano VD, Leoncini E, Zacho J, Martinelli I, Emmerich J, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013 Aug 1;28(8):621-47. DOI: 10.1007/s10654-013-9825-8 9. Hickey

Open access
Recurrent Arterial and Venous Thrombotic Events in a Patient with Psoriasis. Impact of PAI-1 Polymorphism: A Case Report

References 1. Azfar R, Gelfand J. Psoriasis and metabolic disease: Epidemiology and pathophysiology. Curr Opin Rheumatol. 2008;20(4):416-22. 2. Friedewald E, Cather C, Gelfand M, Gordon B, Gibbons H, Grundy S. AJCeditor's consensus: psoriasis and coronary artery disease. Am J Cardiol. 2008;102(12):1631-43. 3. Goldhaber S. Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010;56(1):1-7. 4. Machlus K, Aleman M, Wolberg A. Update on venous thromboembolism: risk factors, mechanisms, and

Open access
Involvement of inflammatory markers in pathogenesis of venous thromboembolism

References 1. Poredos P, Jezovnik MK. The Role of Inflammation in Venous Thromboembolism and the Link Between Arterial and Venous Thrombosis. Int Angiol 2007;26:306-11. 2. Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 2005;94:362-5. DOI: 10.1160/th05-04-0266 3. Jo JY, Lee MY, Lee JW, Rho BH, Choi WI. Leukocytes and systemic inflammatory response syndrome as prognostic factors in pulmonary embolism patients. BMC Pulm Med

Open access
Homozygous Carrier of Prothrombin G20210A Mutation with Massive Pulmonary Embolism and His Family: Gender Differences of Susceptibility to Mutation

References 1. Segal JB, Brotman DJ, Necochea AJ, et al. Predictive value of Factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation. JAMA 2009;301(23):2472-85. 2. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet 2001;109:369-384. 3. Ivanov P, Komsa-Penkova R, Kovacheva K, et al. Impact of Thrombophilic Genetic Factors on Pulmonary Embolism: Early Onset and Recurrent Incidences. Lung 2007

Open access
An Integrative Approach to the Patient with Thrombophilia / SVEOBUHVATNI PRISTUP BOLESNIKU SA TROMBOFILIJOM

References 1. Nygaard KK, Brown GE. Essential thrombophilia: report of five cases. Arch Intern Med 1937; 59: 82-106. 2. Prandoni P, Lensing AWA, Cogo A, Cuppini S, Villalta S, Carta M, Catellan AM, Polistena P, Bernardi E, Prins MH. The long term clinical course of acute deep venous thrombosis. Ann Int Med 1996, 125(1): 1-7. 3. Hansson PO, Sörbo J, Eriksson, H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Archives of Internal Medicine 2000; 160: 769

Open access
Przewlekłe leczenie przeciwkrzepliwe
Komentarz do artykułu „Sulodeksyd w zapobieganiu nawrotom zakrzepicy żył głębokich – badanie SURVET”

recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007; 92: 199-205. 10.3324/haematol.10516 Pradoni P Noventa F Ghirarduzzi A The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1, 626 patients Haematologica 2007 92 199 205 [3] Carrier M, Le Gal G, Wells PS, Rodgers MA. Systematic

Open access
Venous Thromboembolism Secondary to Adult-Onset Still’s Disease: a Case Report

;19;424-430. 8. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163:1711-1717. doi: 10.1001/archinte.163.14.1711. 9. Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008;358:1037-1052. doi: 10.1056/NEJMra072753. 10. Duketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279:458-462. 11. Pouchot J, Sampalis JS, Carette S, etal. Adult Still

Open access
Coincidence of Malignancy and Congenital Thrombophilia as the Cause of Deep Venous Thrombosis - Case Report and Review of the Literature

-439. 4. Deitcher SR, Rodgers GM. Thrombosis and Antithrombotic Therapy. In: Pine JW, Jr., editor. Wintrobe’s clinical hematology. 12th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 1464-1508. 5. Zaher GF, Abdelaal MA. Venous Thromboembolism in Cancer Patients. In: Abdelaal MA, editor. Pathophysiology and Clinical Aspects of Venous Thromboembolism in Neonates, Renal Disease and Cancer Patients. 1st ed. Rijeka: InTech; 2012. p. 73-114. 6. Kwaan HC. Double Hazard of Thrombophilia and Bleeding in Leukemia. ASH Education Book 2007

Open access
Laboratory Investigation of Thrombophilia / LABORATORIJSKO ISPITIVANJE TROMBOFILIJA

References 1. Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 2005; 3: 1611-17. 2. Cohen AT, Agnelli G, Anderson F, Arcelus JI, Bergqvist D, Brecht JG, et al. Venous thromboembolism (VTE) in Euro pe. The number of VTE events and associated mor bidity and mortality. Thromb Haemost 2007; 98: 756-64. 3. Bronic A. Thromboembolic diseases as biological and clinical syndrome - role of the Mediterranean League against Thromboembolic Diseases. Biochem Med 2010; 20: 9

Open access
Reply: Pulmonary thromboembolism in an emergency hospital: Are our patients different?

acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry . Thromb Haemost. 2017; 117 (7):1326-37. 4. AGNELLI G, BULLER HR, COHEN A, CURTO M, GALLUS AS, JOHNSON M, et al. Oral apixaban for the treatment of acute venous thromboembolism . N Engl J Med. 2013; 369 (9):799-808. 5. HOKUSAI-VTE INVESTIGATORS, BÜLLER HR, DÉCOUSUS H, GROSSO MA, MERCURI M, MIDDELDORP S, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013; 369 (15):1406-15. 6. EINSTEIN

Open access